References
- van den Bent MJ. Diagnosis and management of oligodendroglioma. Semin Oncol 2004;31:645–52.
- Cairncross G, Macdonald D, Ludwin S, et al. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. JCO 1994;12:2013–21.
- Van den Bent MJ, Reni M, Gatta G, Vecht C. Oligodendroglioma. Crit Rev Oncol Hematol 2008;66:262–72.
- Lee IH, Kim ST, Suh YL, et al. Infratentorial oligodendrogliomas: imaging findings in six patients. Acta Radiol 2010;51:213–7.
- Pitt MA, Jones AW, Reeve RS, Cowie RA. Oligodendroglioma of the fourth ventricle with intracranial and spinal oligodendrogliomatosis: a case report. Br J Neurosurg 1992;6:371–4.
- Chen N, Yu T, Gong J, et al. IDH1/2 gene hotspot mutations in central nervous system tumours: analysis of 922 Chinese patients. Pathology 2016;48:675–83.
- Leonardi MA, Lumenta CB. Oligodendrogliomas in the CT/MR-era. Acta Neurochir (Wien) 2001;143:1195–203.
- Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005;353:811–22.
- Schucht P, Ghareeb F, Duffau H. Surgery for low-grade glioma infiltrating the central cerebral region: location as a predictive factor for neurological deficit, epileptological outcome, and quality of life. J Neurosurg 2013;119:318–23.
- Elefante A, Peca C, Del Basso De Caro ML, et al. Symptomatic spinal cord metastasis from cerebral oligodendroglioma. Neurol Sci 2012;33:609–13.
- Grabb PA, Albright AL, Pang D. Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery 1992;30:64–71.